Announcements Trials

Browse Landscape

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 1890 Carcinoma, Non-Small-Cell Lung 1350 Prostatic Neoplasms 983 Colorectal Neoplasms 852 Multiple Myeloma 741 Leukemia, Myeloid, Acute 725 Neoplasms 693 Lung Neoplasms 680 Neoplasm Metastasis 643 Lymphoma 579 Carcinoma, Hepatocellular 572 Pancreatic Neoplasms 568 Stomach Neoplasms 523 Leukemia 511 Recurrence 492 Leukemia, Lymphocytic, Chronic, B-Cell 459 Precursor Cell Lymphoblastic Leukemia-Lymphoma 452 Melanoma 451 Lymphoma, Non-Hodgkin 443 Ovarian Neoplasms 429 Lymphoma, Large B-Cell, Diffuse 423 Squamous Cell Carcinoma of Head and Neck 416 Myelodysplastic Syndromes 416 Head and Neck Neoplasms 406 Brain Neoplasms 403 Rectal Neoplasms 397 Glioblastoma 375 Carcinoma, Renal Cell 350 Hodgkin Disease 338 Esophageal Neoplasms 337

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × OTHER × Advanced Kidney Cancer × Clear all

NCT05485883 2022-08-08

TILUR

Tianjin Medical University Second Hospital

Phase 2 Unknown

Advanced Kidney Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡